Search
+
    SEARCHED FOR:

    ORIENT PRESS LTD Q4 RESULTS

    FII selloff hits Rs 30,000 crore since Budget but why aren't alarm bells ringing?

    FIIs have sold Indian stocks worth Rs 30,000 crore since the Budget due to high valuations and global economic concerns. Despite the sell-off, Indian markets remained resilient due to strong domestic investor support. Analysts expect FII behavior to improve by November as key global economic conditions stabilize.

    Q1 results this week: HAL, Ola Electric, Vodafone Idea, IRFC, and Nykaa among 85 companies to announce quarterly earnings

    Several widely followed companies, including Vodafone Idea, Hindustan Aeronautics (HAL), Mazagon Dock, Hero MotoCorp, IRFC, IRCTC, HUDCO, Apollo Hospitals, Samvardhana Motherson, GMR Airports Infrastructure, Nykaa, and Ola Electric will be releasing their June quarter report cards this week. Here’s the list:

    LIC stock portfolio surges to Rs 15 lakh crore, 95 stocks sold in Q1

    Life Insurance Corporation of India's equity portfolio has nearly doubled in three years to Rs 15.72 lakh crore. In the June quarter, LIC reduced stakes in 95 stocks, including Bank of Maharashtra, while increasing investments in firms such as Infosys and TCS. Fund managers advise rotating into value sectors for optimal returns.

    Page Industries Q1 Results: Net profit rises 4.3% YoY to Rs 165.22 crore

    The revenue increased by 3.9% from Rs. 1,229.07 crores to Rs. 1,277.52 crores in the period under review. The sales volume grew by 2.6% year-on-year to 5.74 crore pieces

    Bank of Baroda Q1 Results: Profit rises 9.5% to Rs 4,458 crore

    Bank of Baroda (BoB) on Wednesday reported a 10 per cent increase in standalone net profit to Rs 4,458 crore in the June 2024 quarter, helped by a decline in bad loans. The state-owned bank had posted a net profit of Rs 4,070 crore in the year-ago period.

    Cipla's North America business revenue hits record high in Q1 at $250 million

    Cipla's North American business achieved a record $250 million revenue in Q1 FY25, a 13% year-on-year growth. The company's branded prescription business in India grew 10%, while overall India growth was offset by trade generics softness. Cipla's South Africa revenue grew 19% YoY in local currency terms. Net profit rose 17.4% to Rs 1,178 crore.

    The Economic Times
    BACK TO TOP